As one of Cancer Research UK’s longest and most loyal partners, Ticketmaster has been a fundraising partner for the charity since 2015. The last six years have seen the team take on many fundraising challenges – from karaoke, to dancing, to boxing, to baking, to hitting the streets in blue bibs to collect coins for World Cancer Day. These staff efforts, combined with charity upsells on the Ticketmaster website, have all culminated in reaching this huge £1m fundraising milestone.

“This is such a proud moment for the team who have put so much into our partnership with Cancer Research UK over the last six years”, said Andrew Parsons, MD Ticketmaster UK. “We have all been touched by cancer in some way, so I think seeing first-hand exactly how the funds raised have been used is hugely rewarding. This is just the beginning for us, we’ve got so much more in the pipeline and look forward to hitting the next big milestone!”  

Caro Evans, Director of Partnerships at Cancer Research UK said “I am thrilled that Ticketmaster have reached this incredible milestone and would like to send a huge thank you to all their staff and fans who have consistently continued to drive fundraising for Cancer Research UK through thick and thin over the past six years.  Never before has the support of our partners been more vital for us to be able to realise our vision to bring forward the day when all cancers are cured.  Thank you.” 

Where does the money go?

The money raised by Ticketmaster has helped Cancer Research UK continue to work with researchers, doctors and nurses to help prevent, diagnose and treat cancer, making progress towards their ambition of seeing 3 in 4 people with cancer survive  for 10 years or more by 2034.

A couple of examples of the very real and incredible life-saving research that Cancer Research UK has been able to fund because of fundraising efforts, including the amazing donations from Ticketmaster include:

  • Cancer Research UK researchers develop a new, highly sensitive blood test that monitors breast cancer patients 10x better than ever before.
  • Cancer Research UK funded scientists find that a sponge-on-a-string device can effectively identify cases of Barrett’s oesophagus that may lead to oesophageal cancer – the results show that this tool detects 10 times more cases of Barrett’s oesophagus than GP’s ordinarily do.
  • The ‘MARIETTA trial’ was launched, testing a new treatment regime for people with a rare type of lymphoma that has spread to the brain or spine. The team published results showing that the new regime appears to drastically improve survival for certain patients.

To find out more visit

Expert Partnership
Community Programs
Work With Us
Andy White, Freelance WordPress Developer London